Brave new technologies issue

doi:10.1136/bmj.321.7252.51

BMJ 2000;321:51 ( 1 July )

Letters

Brave new technologies issue

November (with apologies to Thomas Hood)

Noble but dismal

Someone should be sacked

Clever technology looking for a purpose

Sad example of inappropriate use of new technologies in publishing

On a road to nowhere

Support from the future

Revolutionary delivery and management of information

Snoozing with the journal may not be informative

Step towards doing medicine with people rather than for or to them

Summary of responses

November (with apologies to Thomas Hood)

The first 150 words of the full text of this article appear below.

No sun $---$ no moon!
No morn $---$ no noon!
No dawn $---$ no dusk!
No fruits, no flowers, no leaves, no birds $---$ November.
Noscientific editorials $---$ no news!
No papers $---$ no book reviews!
No letters, no fillers, no obits,
Minerva alone to serveour wits.
No proper time of day,
No proper BMJ.
November 13th brought no satisfaction.¹
Please not again $---$ norepetition!

James A S Dickson, retired consultant paediatric surgeon.
Sheffield S10 4GR j.a.s.dickson@sheffield.ac.uk

1.	New technologies in medicine. BMJ 1999;319 (7220). (13 November.)

Noble but dismal

EDITOR $---$ Oh dear! The special issue on new technologies in medicine . . . what can I say?¹

Noble, brave, trendy $---$ but dismallyuninteresting.

Unreadable. Contentless.Annoying.

Still, the paper makes for useful you-know-what in the smallest room in thehouse.

Keith J Russell, general practitioner.
Tranent EH33 2JX drkjr@compuserve.com

1.	New technologies in medicine. BMJ 1999;319 (7220). (13 November.)

Someone should be sacked

EDITOR $---$ The BMJ of 13 November is dreadful.¹ It is almost impossible to read because the text has been overlaid by absurdpictures on almost every page. To start asking readers of bmj.comabout readability v appraisability completely misses the pointwhen the corresponding paper version is totally unreadable. . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Article

Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy: G Preclik, S Grüne, H G Leser, J Lebherz, W Heldwein, K Machka, A Holstege, and W V Kern
BMJ 1999 319: 881. [Abstract] [Full Text] [PDF]